0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Oral Anti-allergic Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-13O14163
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oral Anti allergic Drugs Market Research Report 2023
BUY CHAPTERS

Oral Anti-allergic Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-13O14163
Report
October 2024
Pages:144
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oral Anti-allergic Drugs - Market Size

The global market for Oral Anti-allergic Drugs was estimated to be worth US$ 27710 million in 2023 and is forecast to a readjusted size of US$ 35910 million by 2030 with a CAGR of 3.8% during the forecast period 2024-2030

Oral Anti-allergic Drugs - Market

Oral Anti-allergic Drugs - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Anti-allergic Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oral Anti-allergic Drugs by region & country, by Type, and by Application.
The Oral Anti-allergic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Anti-allergic Drugs.
Market Segmentation

Scope of Oral Anti-allergic Drugs - Market Report

Report Metric Details
Report Name Oral Anti-allergic Drugs - Market
Forecasted market size in 2030 US$ 35910 million
CAGR 3.8%
Forecasted years 2024 - 2030
Segment by Type:
  • Antihistamine Drugs
  • Allergic Mediator Release Agent
  • Immunosuppressant Drugs
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Johnson & Johnson, Merck, Teva, GlaxoSmithKline, Bayer, Almirall, Pfizer, AstraZeneca, Sun Pharma, Novartis, Boehringer Ingelheim, UCB Pharma, Yangtze River Pharmaceutical Group, Hainan Poly Pharm, Chongqing Huapont Pharmaceutical, Dawnrays Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Oral Anti-allergic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Oral Anti-allergic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Oral Anti-allergic Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Oral Anti-allergic Drugs - Market size in 2030?

Ans: The Oral Anti-allergic Drugs - Market size in 2030 will be US$ 35910 million.

Who are the main players in the Oral Anti-allergic Drugs - Market report?

Ans: The main players in the Oral Anti-allergic Drugs - Market are Sanofi, Johnson & Johnson, Merck, Teva, GlaxoSmithKline, Bayer, Almirall, Pfizer, AstraZeneca, Sun Pharma, Novartis, Boehringer Ingelheim, UCB Pharma, Yangtze River Pharmaceutical Group, Hainan Poly Pharm, Chongqing Huapont Pharmaceutical, Dawnrays Pharma

What are the Application segmentation covered in the Oral Anti-allergic Drugs - Market report?

Ans: The Applications covered in the Oral Anti-allergic Drugs - Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Oral Anti-allergic Drugs - Market report?

Ans: The Types covered in the Oral Anti-allergic Drugs - Market report are Antihistamine Drugs, Allergic Mediator Release Agent, Immunosuppressant Drugs

1 Market Overview
1.1 Oral Anti-allergic Drugs Product Introduction
1.2 Global Oral Anti-allergic Drugs Market Size Forecast
1.2.1 Global Oral Anti-allergic Drugs Sales Value (2019-2030)
1.2.2 Global Oral Anti-allergic Drugs Sales Volume (2019-2030)
1.2.3 Global Oral Anti-allergic Drugs Sales Price (2019-2030)
1.3 Oral Anti-allergic Drugs Market Trends & Drivers
1.3.1 Oral Anti-allergic Drugs Industry Trends
1.3.2 Oral Anti-allergic Drugs Market Drivers & Opportunity
1.3.3 Oral Anti-allergic Drugs Market Challenges
1.3.4 Oral Anti-allergic Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oral Anti-allergic Drugs Players Revenue Ranking (2023)
2.2 Global Oral Anti-allergic Drugs Revenue by Company (2019-2024)
2.3 Global Oral Anti-allergic Drugs Players Sales Volume Ranking (2023)
2.4 Global Oral Anti-allergic Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Oral Anti-allergic Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Oral Anti-allergic Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Oral Anti-allergic Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Oral Anti-allergic Drugs
2.9 Oral Anti-allergic Drugs Market Competitive Analysis
2.9.1 Oral Anti-allergic Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Oral Anti-allergic Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anti-allergic Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antihistamine Drugs
3.1.2 Allergic Mediator Release Agent
3.1.3 Immunosuppressant Drugs
3.2 Global Oral Anti-allergic Drugs Sales Value by Type
3.2.1 Global Oral Anti-allergic Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Oral Anti-allergic Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Oral Anti-allergic Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Oral Anti-allergic Drugs Sales Volume by Type
3.3.1 Global Oral Anti-allergic Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Oral Anti-allergic Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Oral Anti-allergic Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Oral Anti-allergic Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Oral Anti-allergic Drugs Sales Value by Application
4.2.1 Global Oral Anti-allergic Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Oral Anti-allergic Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Oral Anti-allergic Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Oral Anti-allergic Drugs Sales Volume by Application
4.3.1 Global Oral Anti-allergic Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Oral Anti-allergic Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Oral Anti-allergic Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Oral Anti-allergic Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Oral Anti-allergic Drugs Sales Value by Region
5.1.1 Global Oral Anti-allergic Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Oral Anti-allergic Drugs Sales Value by Region (2019-2024)
5.1.3 Global Oral Anti-allergic Drugs Sales Value by Region (2025-2030)
5.1.4 Global Oral Anti-allergic Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Oral Anti-allergic Drugs Sales Volume by Region
5.2.1 Global Oral Anti-allergic Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Oral Anti-allergic Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Oral Anti-allergic Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Oral Anti-allergic Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Oral Anti-allergic Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Oral Anti-allergic Drugs Sales Value, 2019-2030
5.4.2 North America Oral Anti-allergic Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Oral Anti-allergic Drugs Sales Value, 2019-2030
5.5.2 Europe Oral Anti-allergic Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Oral Anti-allergic Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Oral Anti-allergic Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Oral Anti-allergic Drugs Sales Value, 2019-2030
5.7.2 South America Oral Anti-allergic Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Oral Anti-allergic Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Oral Anti-allergic Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oral Anti-allergic Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Oral Anti-allergic Drugs Sales Value
6.2.1 Key Countries/Regions Oral Anti-allergic Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Oral Anti-allergic Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Oral Anti-allergic Drugs Sales Value, 2019-2030
6.3.2 United States Oral Anti-allergic Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Oral Anti-allergic Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Oral Anti-allergic Drugs Sales Value, 2019-2030
6.4.2 Europe Oral Anti-allergic Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Oral Anti-allergic Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Oral Anti-allergic Drugs Sales Value, 2019-2030
6.5.2 China Oral Anti-allergic Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Oral Anti-allergic Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Oral Anti-allergic Drugs Sales Value, 2019-2030
6.6.2 Japan Oral Anti-allergic Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Oral Anti-allergic Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Oral Anti-allergic Drugs Sales Value, 2019-2030
6.7.2 South Korea Oral Anti-allergic Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Oral Anti-allergic Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Oral Anti-allergic Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Oral Anti-allergic Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Oral Anti-allergic Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Oral Anti-allergic Drugs Sales Value, 2019-2030
6.9.2 India Oral Anti-allergic Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Oral Anti-allergic Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Company Information
7.1.2 Sanofi Introduction and Business Overview
7.1.3 Sanofi Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sanofi Oral Anti-allergic Drugs Product Offerings
7.1.5 Sanofi Recent Development
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Information
7.2.2 Johnson & Johnson Introduction and Business Overview
7.2.3 Johnson & Johnson Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Johnson & Johnson Oral Anti-allergic Drugs Product Offerings
7.2.5 Johnson & Johnson Recent Development
7.3 Merck
7.3.1 Merck Company Information
7.3.2 Merck Introduction and Business Overview
7.3.3 Merck Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck Oral Anti-allergic Drugs Product Offerings
7.3.5 Merck Recent Development
7.4 Teva
7.4.1 Teva Company Information
7.4.2 Teva Introduction and Business Overview
7.4.3 Teva Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Teva Oral Anti-allergic Drugs Product Offerings
7.4.5 Teva Recent Development
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Information
7.5.2 GlaxoSmithKline Introduction and Business Overview
7.5.3 GlaxoSmithKline Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 GlaxoSmithKline Oral Anti-allergic Drugs Product Offerings
7.5.5 GlaxoSmithKline Recent Development
7.6 Bayer
7.6.1 Bayer Company Information
7.6.2 Bayer Introduction and Business Overview
7.6.3 Bayer Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Bayer Oral Anti-allergic Drugs Product Offerings
7.6.5 Bayer Recent Development
7.7 Almirall
7.7.1 Almirall Company Information
7.7.2 Almirall Introduction and Business Overview
7.7.3 Almirall Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Almirall Oral Anti-allergic Drugs Product Offerings
7.7.5 Almirall Recent Development
7.8 Pfizer
7.8.1 Pfizer Company Information
7.8.2 Pfizer Introduction and Business Overview
7.8.3 Pfizer Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Pfizer Oral Anti-allergic Drugs Product Offerings
7.8.5 Pfizer Recent Development
7.9 AstraZeneca
7.9.1 AstraZeneca Company Information
7.9.2 AstraZeneca Introduction and Business Overview
7.9.3 AstraZeneca Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.9.4 AstraZeneca Oral Anti-allergic Drugs Product Offerings
7.9.5 AstraZeneca Recent Development
7.10 Sun Pharma
7.10.1 Sun Pharma Company Information
7.10.2 Sun Pharma Introduction and Business Overview
7.10.3 Sun Pharma Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Sun Pharma Oral Anti-allergic Drugs Product Offerings
7.10.5 Sun Pharma Recent Development
7.11 Novartis
7.11.1 Novartis Company Information
7.11.2 Novartis Introduction and Business Overview
7.11.3 Novartis Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Novartis Oral Anti-allergic Drugs Product Offerings
7.11.5 Novartis Recent Development
7.12 Boehringer Ingelheim
7.12.1 Boehringer Ingelheim Company Information
7.12.2 Boehringer Ingelheim Introduction and Business Overview
7.12.3 Boehringer Ingelheim Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Boehringer Ingelheim Oral Anti-allergic Drugs Product Offerings
7.12.5 Boehringer Ingelheim Recent Development
7.13 UCB Pharma
7.13.1 UCB Pharma Company Information
7.13.2 UCB Pharma Introduction and Business Overview
7.13.3 UCB Pharma Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.13.4 UCB Pharma Oral Anti-allergic Drugs Product Offerings
7.13.5 UCB Pharma Recent Development
7.14 Yangtze River Pharmaceutical Group
7.14.1 Yangtze River Pharmaceutical Group Company Information
7.14.2 Yangtze River Pharmaceutical Group Introduction and Business Overview
7.14.3 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Product Offerings
7.14.5 Yangtze River Pharmaceutical Group Recent Development
7.15 Hainan Poly Pharm
7.15.1 Hainan Poly Pharm Company Information
7.15.2 Hainan Poly Pharm Introduction and Business Overview
7.15.3 Hainan Poly Pharm Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Hainan Poly Pharm Oral Anti-allergic Drugs Product Offerings
7.15.5 Hainan Poly Pharm Recent Development
7.16 Chongqing Huapont Pharmaceutical
7.16.1 Chongqing Huapont Pharmaceutical Company Information
7.16.2 Chongqing Huapont Pharmaceutical Introduction and Business Overview
7.16.3 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Product Offerings
7.16.5 Chongqing Huapont Pharmaceutical Recent Development
7.17 Dawnrays Pharma
7.17.1 Dawnrays Pharma Company Information
7.17.2 Dawnrays Pharma Introduction and Business Overview
7.17.3 Dawnrays Pharma Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Dawnrays Pharma Oral Anti-allergic Drugs Product Offerings
7.17.5 Dawnrays Pharma Recent Development
8 Industry Chain Analysis
8.1 Oral Anti-allergic Drugs Industrial Chain
8.2 Oral Anti-allergic Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oral Anti-allergic Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Oral Anti-allergic Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Oral Anti-allergic Drugs Market Trends
    Table 2. Oral Anti-allergic Drugs Market Drivers & Opportunity
    Table 3. Oral Anti-allergic Drugs Market Challenges
    Table 4. Oral Anti-allergic Drugs Market Restraints
    Table 5. Global Oral Anti-allergic Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Oral Anti-allergic Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Oral Anti-allergic Drugs Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Oral Anti-allergic Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Oral Anti-allergic Drugs Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Oral Anti-allergic Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Oral Anti-allergic Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Oral Anti-allergic Drugs
    Table 13. Global Oral Anti-allergic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anti-allergic Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Oral Anti-allergic Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Oral Anti-allergic Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Oral Anti-allergic Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Oral Anti-allergic Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Oral Anti-allergic Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Oral Anti-allergic Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Oral Anti-allergic Drugs Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Oral Anti-allergic Drugs Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Oral Anti-allergic Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Oral Anti-allergic Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Oral Anti-allergic Drugs Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Oral Anti-allergic Drugs Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Oral Anti-allergic Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Oral Anti-allergic Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Oral Anti-allergic Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Oral Anti-allergic Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Oral Anti-allergic Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Oral Anti-allergic Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Oral Anti-allergic Drugs Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Oral Anti-allergic Drugs Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Oral Anti-allergic Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Oral Anti-allergic Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Oral Anti-allergic Drugs Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Oral Anti-allergic Drugs Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Oral Anti-allergic Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Oral Anti-allergic Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Oral Anti-allergic Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Oral Anti-allergic Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Oral Anti-allergic Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Oral Anti-allergic Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Oral Anti-allergic Drugs Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Oral Anti-allergic Drugs Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Oral Anti-allergic Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Oral Anti-allergic Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Oral Anti-allergic Drugs Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Oral Anti-allergic Drugs Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Oral Anti-allergic Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Oral Anti-allergic Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Oral Anti-allergic Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Oral Anti-allergic Drugs Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Oral Anti-allergic Drugs Sales Volume, (2025-2030) & (K Units)
    Table 57. Sanofi Company Information
    Table 58. Sanofi Introduction and Business Overview
    Table 59. Sanofi Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Sanofi Oral Anti-allergic Drugs Product Offerings
    Table 61. Sanofi Recent Development
    Table 62. Johnson & Johnson Company Information
    Table 63. Johnson & Johnson Introduction and Business Overview
    Table 64. Johnson & Johnson Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Johnson & Johnson Oral Anti-allergic Drugs Product Offerings
    Table 66. Johnson & Johnson Recent Development
    Table 67. Merck Company Information
    Table 68. Merck Introduction and Business Overview
    Table 69. Merck Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Merck Oral Anti-allergic Drugs Product Offerings
    Table 71. Merck Recent Development
    Table 72. Teva Company Information
    Table 73. Teva Introduction and Business Overview
    Table 74. Teva Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Teva Oral Anti-allergic Drugs Product Offerings
    Table 76. Teva Recent Development
    Table 77. GlaxoSmithKline Company Information
    Table 78. GlaxoSmithKline Introduction and Business Overview
    Table 79. GlaxoSmithKline Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. GlaxoSmithKline Oral Anti-allergic Drugs Product Offerings
    Table 81. GlaxoSmithKline Recent Development
    Table 82. Bayer Company Information
    Table 83. Bayer Introduction and Business Overview
    Table 84. Bayer Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Bayer Oral Anti-allergic Drugs Product Offerings
    Table 86. Bayer Recent Development
    Table 87. Almirall Company Information
    Table 88. Almirall Introduction and Business Overview
    Table 89. Almirall Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Almirall Oral Anti-allergic Drugs Product Offerings
    Table 91. Almirall Recent Development
    Table 92. Pfizer Company Information
    Table 93. Pfizer Introduction and Business Overview
    Table 94. Pfizer Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Pfizer Oral Anti-allergic Drugs Product Offerings
    Table 96. Pfizer Recent Development
    Table 97. AstraZeneca Company Information
    Table 98. AstraZeneca Introduction and Business Overview
    Table 99. AstraZeneca Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. AstraZeneca Oral Anti-allergic Drugs Product Offerings
    Table 101. AstraZeneca Recent Development
    Table 102. Sun Pharma Company Information
    Table 103. Sun Pharma Introduction and Business Overview
    Table 104. Sun Pharma Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Sun Pharma Oral Anti-allergic Drugs Product Offerings
    Table 106. Sun Pharma Recent Development
    Table 107. Novartis Company Information
    Table 108. Novartis Introduction and Business Overview
    Table 109. Novartis Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Novartis Oral Anti-allergic Drugs Product Offerings
    Table 111. Novartis Recent Development
    Table 112. Boehringer Ingelheim Company Information
    Table 113. Boehringer Ingelheim Introduction and Business Overview
    Table 114. Boehringer Ingelheim Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Boehringer Ingelheim Oral Anti-allergic Drugs Product Offerings
    Table 116. Boehringer Ingelheim Recent Development
    Table 117. UCB Pharma Company Information
    Table 118. UCB Pharma Introduction and Business Overview
    Table 119. UCB Pharma Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. UCB Pharma Oral Anti-allergic Drugs Product Offerings
    Table 121. UCB Pharma Recent Development
    Table 122. Yangtze River Pharmaceutical Group Company Information
    Table 123. Yangtze River Pharmaceutical Group Introduction and Business Overview
    Table 124. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Product Offerings
    Table 126. Yangtze River Pharmaceutical Group Recent Development
    Table 127. Hainan Poly Pharm Company Information
    Table 128. Hainan Poly Pharm Introduction and Business Overview
    Table 129. Hainan Poly Pharm Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Hainan Poly Pharm Oral Anti-allergic Drugs Product Offerings
    Table 131. Hainan Poly Pharm Recent Development
    Table 132. Chongqing Huapont Pharmaceutical Company Information
    Table 133. Chongqing Huapont Pharmaceutical Introduction and Business Overview
    Table 134. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Product Offerings
    Table 136. Chongqing Huapont Pharmaceutical Recent Development
    Table 137. Dawnrays Pharma Company Information
    Table 138. Dawnrays Pharma Introduction and Business Overview
    Table 139. Dawnrays Pharma Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Dawnrays Pharma Oral Anti-allergic Drugs Product Offerings
    Table 141. Dawnrays Pharma Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Oral Anti-allergic Drugs Downstream Customers
    Table 145. Oral Anti-allergic Drugs Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oral Anti-allergic Drugs Product Picture
    Figure 2. Global Oral Anti-allergic Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Oral Anti-allergic Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Oral Anti-allergic Drugs Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Oral Anti-allergic Drugs Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Oral Anti-allergic Drugs Report Years Considered
    Figure 7. Global Oral Anti-allergic Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Oral Anti-allergic Drugs Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Anti-allergic Drugs Revenue in 2023
    Figure 10. Oral Anti-allergic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Antihistamine Drugs Picture
    Figure 12. Allergic Mediator Release Agent Picture
    Figure 13. Immunosuppressant Drugs Picture
    Figure 14. Global Oral Anti-allergic Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Oral Anti-allergic Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Oral Anti-allergic Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Oral Anti-allergic Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Oral Anti-allergic Drugs Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Hospital Pharmacies
    Figure 20. Product Picture of Retail Pharmacies
    Figure 21. Product Picture of Online Pharmacies
    Figure 22. Global Oral Anti-allergic Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Oral Anti-allergic Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Oral Anti-allergic Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Oral Anti-allergic Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Oral Anti-allergic Drugs Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Oral Anti-allergic Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Oral Anti-allergic Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Oral Anti-allergic Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Oral Anti-allergic Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Oral Anti-allergic Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Oral Anti-allergic Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Oral Anti-allergic Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Oral Anti-allergic Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Oral Anti-allergic Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Oral Anti-allergic Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Oral Anti-allergic Drugs Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Oral Anti-allergic Drugs Sales Volume (%), (2019-2030)
    Figure 39. United States Oral Anti-allergic Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Oral Anti-allergic Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Oral Anti-allergic Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Oral Anti-allergic Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Oral Anti-allergic Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Oral Anti-allergic Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Oral Anti-allergic Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Oral Anti-allergic Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Oral Anti-allergic Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Oral Anti-allergic Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Oral Anti-allergic Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Oral Anti-allergic Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Oral Anti-allergic Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Oral Anti-allergic Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Oral Anti-allergic Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Oral Anti-allergic Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Oral Anti-allergic Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Oral Anti-allergic Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Oral Anti-allergic Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Oral Anti-allergic Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Oral Anti-allergic Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 60. Oral Anti-allergic Drugs Industrial Chain
    Figure 61. Oral Anti-allergic Drugs Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS